Y-Intercept (Hong Kong) Ltd

Position in BHC — Bausch Health Companies Inc.

CIK 1772875 HONG KONG, K3

Position in BHC

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$458,830

-$105,065 QoQ

Shares Held

93,069

-10.9% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#83

of 220 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. BHC ranks #15 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	147,055	$10,567,372
2	UTHR	UNITED THERAPEUTICS Corp	14,271	$7,732,455
3	HIMS	Hims & Hers Health, Inc.	190,145	$6,592,327
4	INDV	Indivior Pharmaceuticals, Inc.	136,725	$5,609,826
5	VTRS	Viatris Inc	331,130	$5,258,344
6	PRGO	PERRIGO Co plc	346,586	$3,601,028
7	XERS	Xeris Biopharma Holdings, Inc.	411,346	$3,257,860
8	ANIP	Ani Pharmaceuticals Inc	34,505	$2,856,323

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$458,830	93,069	-10.9%	Shares	Sole	2026-07-14
2026-03-31	$563,895	104,425	-50.8%	Shares	Sole	2026-04-27
2025-12-31	$1,475,005	212,231	+218.9%	Shares	Sole	2026-02-13
2025-09-30	$429,312	66,560	+168.8%	Shares	Sole	2025-10-31
2025-06-30	$164,908	24,761	-76.6%	Shares	Sole	2025-08-01
2024-03-31	$1,122,166	105,765	-27.7%	Shares	Sole	2024-05-10
2023-12-31	$1,172,524	146,200	+198.4%	Shares	Sole	2024-02-13
2022-06-30	$409,573	48,992	+292.0%	Shares	Sole	2022-08-08
2021-03-31	$396,718	12,499	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.